MyAverix Finance
F · Healthcare
Prostatype Genomics AB (publ) (PGO0)
Diagnostics & Research
Prostatype Genomics AB (publ) (PGO0) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-30, reported market cap is $3.87M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PGO0
Prostatype Genomics AB (publ) (PGO0) — FAQ
What is Prostatype Genomics AB (publ)'s market cap?
Prostatype Genomics AB (publ) (PGO0) has a reported market cap of $3.87M (data as of 2026-03-30).
What is PGO0's P/E ratio?
The price-to-earnings (P/E) ratio for Prostatype Genomics AB (publ) (PGO0) is 18.00 (data as of 2026-03-30).
Does Prostatype Genomics AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Prostatype Genomics AB (publ) (PGO0). Check the MyAverix Finance app for the latest dividend data.
What sector is Prostatype Genomics AB (publ) in?
Prostatype Genomics AB (publ) (PGO0) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is PGO0 listed on?
PGO0 is listed on F.
What is Prostatype Genomics AB (publ)'s net margin?
Prostatype Genomics AB (publ) (PGO0) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.